Lower Doses of Antibiotics and Shorter Treatment Durations Just As Effective on Children with Pneumonia: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Fluoroquinolone Nerve Damage Lawyers to be Appointed to Leadership Roles in MDL March 15, 2016 Irvin Jackson Add Your Comments As a growing number of Levaquin lawsuits, Avelox lawsuits and Cipro lawsuits continue to be filed throughout the federal court by individuals diagnosed with permanent nerve damage, the U.S. District Judge presiding over the litigation is being asked to appoint a group of lawyers who will serve in various leadership roles in the recently established multidistrict litigation (MDL). There are currently at least 360 complaints filed throughout the federal court system over the side effects of antibiotics that are part of a class of medications known as fluoroquinolones, indicating that the makers of Levaquin, Avelox and Cipro failed to adequately warn users about the risk of long-term nerve problems known as peripheral neuropathy. As lawyers continue to review and file cases for individuals nationwide, it is ultimately expected that several thousand complaints will be included in MDL proceedings established before U.S. District Judge John R. Tunheim in the District of Minnesota, where all cases filed throughout the federal court system have been centralized to reduce duplicative discovery, avoid conflicting pretrial rulings from different courts and to serve the convenience of the parties, witnesses and the courts. Learn More About Antibiotic Aortic Aneurysm Lawsuits Side Effects of Avelox, Levaquin, Cipro and Other Fluoroquinolone Antibiotics May Cause Peripheral Neuropathy. Lawyers Are Reviewing Lawsuits Nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Antibiotic Aortic Aneurysm Lawsuits Side Effects of Avelox, Levaquin, Cipro and Other Fluoroquinolone Antibiotics May Cause Peripheral Neuropathy. Lawyers Are Reviewing Lawsuits Nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In a joint agenda (PDF) filed in advance of a status conference scheduled before Judge Tunheim this afternoon, the parties have asked that the Court discuss the appointment of lead counsel and a steering committee for the plaintiffs, as well as liaison counsel for both parties. As part of the coordinated pretrial proceedings in complex pharmaceutical litigation, it is common for a small group of attorneys to serve in leadership roles, conducting common discovery into generic issues that apply to all claims, arguing motions before the Court and negotiating stipulations or settlements in the cases. These lawyers will take actions that benefit all plaintiffs in the litigation. All of the fluoroquinolone nerve damage lawsuits pending before Judge Tunheim involve similar allegations, claiming that individuals developed permanent peripheral neuropathy after using the popular antibiotics. The litigation has emerged since the FDA required makers of all fluoroquinolone-based antibiotics to update the warning labels in August 2013, adding information about the risk that nerve damage may be permanent. While prior warnings provided with drugs like Levaquin, Avelox and Cipro indicated that some users experienced temporary nerve damage in rare cases, plaintiffs allege that the drug makers should have provided much stronger warnings and disclosed the risk of long-lasting nerve damage, which may last for months or even years. Peripheral neuropathy involves damage to the nerves that may impair sensation, movement and other aspects of health. This may leave users with persistent pain, burning, tingling, numbness, weakness and sensitivity to light touches, temperature and motion in the arms and legs, as well as other problems that cause a major disruption to daily activities. Plaintiffs allege that the makers of Levaquin, Avelox and Cipro should have provided these warnings years ago, noting that the first indication of a possible link between long-term peripheral neuropathy and fluoroquinolone antibiotics came in a study published in 2001. If adequate warnings had been provided about the risk of permanent neuropathy problems, plaintiffs indicate that they may have avoided painful and debilitating injuries. In addition to addressing the appointment of lawyers to various leadership rules, other agenda items that the parties ask Judge Tunheim to address during the status conference set for this afternoon at 1:30 p.m. include the status of federal and state court filings, the status of pending motions for remand and the entry of deadlines for proposed protective orders, discovery protocals, a case management plan and the selection of early bellwether trials. It is expected that Judge Tunheim will eventually schedule a series of early test trials to help gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the litigation. While the outcome of these bellwether trials will not be binding on other cases, they may facilitate eventual negotiations to settle cases and avoid the need for hundreds of individual trials to be scheduled throughout the U.S. Tags: Antibiotics, Avelox, Cipro, Levaquin, Nerve Damage, Peripheral Neuropathy Image Credit: | More Antibiotic Lawsuit Stories New Antiseptic Treatment Could Reduce Antibiotic Use For UTIs: Study March 24, 2022 Lower Doses of Antibiotics and Shorter Treatment Durations Just As Effective on Children with Pneumonia: Study November 30, 2021 Levaquin, Similar Antibiotics May Increase Risk of Cardiac Arrest in Hemodialysis Patients: Study October 26, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Lower Doses of Antibiotics and Shorter Treatment Durations Just As Effective on Children with Pneumonia: Study November 30, 2021
Levaquin, Similar Antibiotics May Increase Risk of Cardiac Arrest in Hemodialysis Patients: Study October 26, 2021
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)